The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and Human Services, at which HHS Secretary Alex Azar testified. Released yesterday, the non-binding budget request proposes hundreds of billions of dollars in reductions to Medicare and Medicaid over 10 years. It also contains a number of provisions related to drug pricing, opioids and other health-related issues. In a statement yesterday, AHA President and CEO Rick Pollack said, “Patients should be confident in knowing that their hospital is their lifeline to access care in their community. The cuts proposed today raise serious concerns about how hospitals and health systems can ensure they serve as the safety net for their patients.”  For more on AHA's reaction, see the AHA Stat blog.
 
At today’s hearing, Azar announced that National Cancer Institute Director Norman Sharpless, M.D., will serve as acting Food and Drug Administration commissioner after current commissioner Scott Gottlieb, M.D., departs in about a month.

Related News Articles

Headline
The Medicare Payment Advisory Commission March 15 released its March report to Congress, which includes its recent recommendations for hospital and other…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Blog
The Medicare Payment Advisory Commission (MedPAC) today released its annual March Report advising Congress on the Medicare fee-for-service (FFS) payment…
Headline
The House Energy and Commerce Committee March 12 passed AHA-supported  legislation to reauthorize through 2029 the Dr. Lorna Breen Health Care Provider…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…